Inecalcitol

DB04796InvestigationalSmall molecule

Investigated for use/treatment in prostate cancer, psoriasis and hyperparathyroidism.

Chemical structure of Inecalcitol
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in prostate cancer, psoriasis and hyperparathyroidism.Curator reviewed
Formula / weight
C26H40O3 · 400.603 g/mol (avg)
Code names
TX-522

Resolves to

Structure
InChIKeyHHGRMHMXKPQNGF-WNSNRMDMSA-NSMILES[H][C@@]1(CC[C@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)CC#CC(C)(C)O
Targets

What you can answer from here — as of August 26, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
156Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Inecalcitol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account